Prime DiscoveriesNew York, NYLife SciencesCohort: 2018-2019
Prime Discoveries is The Microbiome Discovery Company. Prime uses AI to discover patterns in the microbiome and is the first to approach clinical grade accuracy for several gut diseases, subtypes, and confounding diseases. Prime is also expanding into colorectal cancer given several recent breakthroughs. Prime will begin by commercializing clinical tests and is beginning validation studies to launch the first clinical microbiome panel for gut diseases, followed by colorectal cancer.
The startup represented here is a graduate of Endless Frontier Labs’ predecessor program, called Creative Destruction Lab-New York City, operated by NYU in partnership with University of Toronto during 2018-2019. The Endless Frontier Labs has no current engagement or affiliation with the Creative Destruction Lab.